◆ 会议时间：2023年9月6日至9日
◆ 会议地点：法国 巴黎

◆ 会议简介：

2023年第6届世界区域麻醉与疼痛医学大会暨第40届欧洲区域麻醉与疼痛治疗协会(ESRA)年会/大会将于2023年9月6日至9日在法国巴黎举行，会议由欧洲区域麻醉与疼痛治疗协会(ESRA)主办。世界区域麻醉与疼痛医学大会每四年举办一届，由五个学会联合举办，分别为：美国区域麻醉与疼痛医学协会(ASRA)、欧洲区域麻醉和疼痛治疗协会(ESRA)、拉丁美洲区域麻醉协会(LASRA)、亚洲大洋洲区域麻醉和疼痛医学协会(AOSRA)、非洲区域麻醉协会(AFSRA)。世界区域麻醉与疼痛医学大会及ESRA麻醉学大会将为临床医生和科学家提供一个世界级的平台，来展示、讨论和交流有关快速发展的区域麻醉和疼痛治疗领域宣的最新见解。

欧洲区域麻醉与疼痛治疗协会(ESRA)成立于1980年，旨在促进欧洲区域麻醉学的交流与进步。ESRA第一次大会于1982年在爱丁堡举行，从那一年起，学会不断发展壮大，目前ESRA在欧洲及其他地区拥有超过4000名成员。未经许可禁止复制转载摘录镜像本站任何内容-国际医学会议网(lingyuint.com)。

6th World Congress on Regional Anesthesia & Pain Medicine
40th Annual Congress of the European Society of Regional Anaesthesia & Pain Therapy

Date: 6-9 September, 2023
Venue: Paris, France

摘要征文投稿：

点此提交摘要>>>Submit Abstract>>>

Download the abstract guidelines

• All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university scientific publications office (or other similar facilities) or by a copy editor, prior to submission.
• The presenting author is requested to ensure that all co-authors are aware of the content of the abstract before submission.
• Submission of an abstract acknowledges your acceptance for the abstract to be published on the Congress website and in the Congress journal supplement.
• Only the abstracts of registered presenting authors will be included in the final programme.
• Each person may submit up to 3 abstracts. The number of abstracts one person may be the presenting author is 3.
• The Scientific Committee will determine whether abstracts will be accepted as Oral or e-poster presentations, with consideration to be given to the author’s preference. Abstracts will be reviewed and assigned to appropriate sessions.
• All submitted abstracts must contain novel data. Abstracts stating “data will be discussed in the presentation” will NOT be accepted.
• If an abstract was previously submitted to a different Congress but was not presented, it can be submitted to this Congress as well. If it was previously presented, it cannot be submitted to WcRAPM 2023.

GUIDELINES

Before you begin, please prepare the following information:
1. Author and co-authors’ details: a) Full first and family name(s) b) Affiliation details: department, institution / hospital, city, state (if relevant), country
You must create the list of authors through a specific form “Create a new author”.
Once created, you may add the authors (first author and co-authors), order them and select a presenter.
Each abstract can only have up to 8 authors, with up to 3 affiliations for each author.

2. Abstract title – limited to 25 words in UPPER CASE

3. Abstract text – limited to 250 words

4. Images, tables and graphs:

• • Graphs and images may be uploaded in a JPG format only. When including a table, it is recommended to save the table as an image and then upload it in to the abstract. A maximum of 3 images can be included per abstract.
  • The maximum file size of each graph/image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload graphs in JPG format only.
  • The abstracts can be edited after submission until the submission deadline. Following the submission deadline, no changes can be made to abstracts.

5. Validation:

Initially, the abstracts are registered under “Draft” status. You will receive an email confirming the registration of your abstract and that it is in draft status. If you do not receive this email within 48 hours, please contact us.

When your abstract is in draft form, you may return to your account at any time to amend the contents or submit the final version. Abstracts with a draft status MUST be submitted formally before the deadline. When you click SUBMIT, your abstract will change to the status “Submitted”, and you will receive a confirmation of your submission by email.

Only abstracts with a “Submitted” status will be forwarded to the abstract reviewers for rating.

注册费：

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。